Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD

E. Papakonstantinou (Basel, Switzerland), M. Karakioulaki (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)

Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Session: Respiratory infections and bronchiectasis outcomes
Session type: Oral Presentation
Number: 2858

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou (Basel, Switzerland), M. Karakioulaki (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland). Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD. 2858

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Serum magnesium levels of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003

Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016


Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Chronic bronchitis and plasma markers of inflammation predict incidence of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 681s
Year: 2007

Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Study on the relation between serum complement (C3, C4) levels and acute exacerbations in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008


Efficiency of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 214s
Year: 2006

Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020




The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate?
Source: Eur Respir J 2007; 30: 80-89
Year: 2007



Serum periostin in patients hospitalized for COPD exacerbations
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD
Source: Eur Respir J 2009; 34: 95-102
Year: 2009